# Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers

> **NCT06952868** · PHASE2 · RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Head and Neck Cancer
- Boron Neutron Capture Therapy

## Interventions

- **DRUG:** Drug: B10 L-BPA Injection

## Key facts

- **NCT ID:** NCT06952868
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-23
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952868, "Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06952868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*